Biotech News
Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025
iridex.gcs-web.com2026-05-06 15:15 EST
Demonstrating continued revenue growth, operational efficiencies and positive cash flow MOUNTAIN VIEW, Calif. , Jan. 12, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure